Coherus Oncology公司
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership52,333 shares
Latest Disclosed Value $ 88,443
Citigroup Inc ownership in CHRS / Coherus Oncology, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 52,333 shares of Coherus Oncology, Inc. (US:CHRS) valued at $88,443 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 192,856 shares of Coherus Oncology, Inc.. This represents a change in shares of -72.86% during the quarter. The current value of the position is $82,424 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (CHRS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CHRS / Coherus Oncology, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F COHERUS ONCOLOGY COM 19249H103 52,333 -140,523 -72.86 88 -67.77 0.0000
2026-02-13 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 192,856 -51,239 -20.99 274 -31.75 0.0001
2025-11-10 2025-09-30 13F COHERUS ONCOLOGY COM 19249H103 244,095 -738,372 -75.15 400 -44.29 0.0002
2025-08-11 2025-06-30 13F COHERUS ONCOLOGY COM 19249H103 982,467 -39,414 -3.86 718 -12.86 0.0004
2025-05-12 2025-03-31 13F COHERUS BIOSCIENCES COM 19249H103 1,021,881 541,280 112.63 825 24.28 0.0004
2025-02-12 2024-12-31 13F COHERUS BIOSCIENCES COM 19249H103 480,601 -38,202 -7.36 663 23.01 0.0004
2024-11-12 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 518,803 54,348 11.70 540 -32.88 0.0003
2024-08-12 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 464,455 -52,261 -10.11 804 -34.93 0.0005
2024-05-10 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 516,716 142,909 38.23 1,235 -0.80 0.0008
2024-02-09 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 373,807 -423,490 -53.12 1,245 -58.27 0.0009
2023-12-06 2023-09-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 797,297 289,194 56.92 2,982 37.44 0.0022
2023-11-09 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 797,297 289,194 2,982 0.0009
2023-08-10 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 508,103 -361,210 -41.55 2,170 -63.52 0.0014
2023-05-11 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 869,313 102,229 13.33 5,946 -2.12 0.0042
2023-02-09 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 767,084 -70,631 -8.43 6,075 -24.53 0.0048
2022-11-10 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 837,715 68,015 8.84 8,050 44.47 0.0058
2022-08-10 2022-06-30 13F COHERUS BIOSCIENCES COM 19249H103 769,700 84,908 12.40 5,572 -36.97 0.0041
2022-05-12 2022-03-31 13F COHERUS BIOSCIENCES COM 19249H103 684,792 -109,604 -13.80 8,840 -30.28 0.0054
2022-02-10 2021-12-31 13F COHERUS BIOSCIENCES COM 19249H103 794,396 151,196 23.51 12,679 22.66 0.0068
2021-11-10 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 643,200 -211,109 -24.71 10,337 -12.51 0.0061
2021-08-10 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 854,309 71,811 9.18 11,815 3.35 0.0071
2021-05-13 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 782,498 222,573 39.75 11,432 17.47 0.0074
2021-02-11 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 559,925 32,630 6.19 9,732 0.64 0.0057
2020-11-12 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 527,295 49,901 10.45 9,670 13.42 0.0063
2020-08-12 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 477,394 401,905 532.40 8,526 596.57 0.0067
2020-05-12 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 75,489 32,190 74.34 1,224 56.92 0.0011
2020-02-12 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 43,299 -44,229 -50.53 780 -56.01 0.0006
2019-11-08 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 87,528 771 0.89 1,773 -7.51 0.0014
2019-08-12 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 86,757 -8,803 -9.21 1,917 47.12 0.0015
2019-05-13 2019-03-31 13F COHERUS BIOSCIENCES COM 19249H103 95,560 -25,136 -20.83 1,303 19.32 0.0013
2019-02-12 2018-12-31 13F COHERUS BIOSCIENCES COM 19249H103 120,696 74,804 163.00 1,092 44.25 0.0011
2018-11-13 2018-09-30 13F COHERUS BIOSCIENCES COM 19249H103 45,892 -121,733 -72.62 757 -67.75 0.0007
2018-08-10 2018-06-30 13F COHERUS BIOSCIENCES COM 19249H103 167,625 34,091 25.53 2,347 59.12 0.0022
2018-05-11 2018-03-31 13F COHERUS BIOSCIENCES COM 19249H103 133,534 95,203 248.37 1,475 337.69 0.0012
2018-02-12 2017-12-31 13F COHERUS BIOSCIENCES COM 19249H103 38,331 9,260 31.85 337 -12.92 0.0003
2017-11-13 2017-09-30 13F COHERUS BIOSCIENCES COM 19249H103 29,071 6,204 27.13 387 17.99 0.0003
2017-08-11 2017-06-30 13F COHERUS BIOSCIENCES COM 19249H103 22,867 22,856 207,781.82 328 0.0003
2017-05-12 2017-03-31 13F COHERUS BIOSCIENCES COM 19249H103 11 -57,457 -99.98 0 -100.00
2017-02-10 2016-12-31 13F COHERUS BIOSCIENCES COM 19249H103 57,468 34,971 155.45 1,618 168.33 0.0015
2016-11-10 2016-09-30 13F COHERUS BIOSCIENCES COM 19249H103 22,497 5,064 29.05 603 105.10 0.0006
2016-08-12 2016-06-30 13F COHERUS BIOSCIENCES COM 19249H103 17,433 351 2.05 294 -19.01 0.0003
2016-05-13 2016-03-31 13F COHERUS BIOSCIENCES COM 19249H103 17,082 11,273 194.06 363 170.90 0.0004
2016-02-12 2015-12-31 13F COHERUS BIOSCIENCES COM 19249H103 5,809 5,801 72,512.50 134 0.0001
2015-11-13 2015-09-30 13F COHERUS BIOSCIENCES COM 19249H103 8 -351 -97.77 0 -100.00
2015-08-13 2015-06-30 13F COHERUS BIOSCIENCES COM 19249H103 359 -18,507 -98.10 11 -98.09 0.0000
2015-05-14 2015-03-31 13F COHERUS BIOSCIENCES COM 19249H103 18,866 17,500 1,281.11 577 2,522.73 0.0006
2015-02-17 2014-12-31 13F COHERUS BIOSCIENCES COM 19249H103 1,366 1,366 22 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-13 2019-03-31 13F COHERUS BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-12 2018-12-31 13F COHERUS BIOSCIENCES COM Call 1,600 0.00 14 -46.15 n/a n/a n/a
2018-11-13 2018-09-30 13F COHERUS BIOSCIENCES COM Call 1,600 -66.67 26 -61.19 n/a n/a n/a
2018-08-10 2018-06-30 13F COHERUS BIOSCIENCES COM Call 4,800 33.33 67 67.50 n/a n/a n/a
2018-05-11 2018-03-31 13F COHERUS BIOSCIENCES COM Call 3,600 38.46 40 73.91 n/a n/a n/a
2018-02-12 2017-12-31 13F COHERUS BIOSCIENCES COM Call 2,600 44.44 23 -4.17 n/a n/a n/a
2017-11-13 2017-09-30 13F COHERUS BIOSCIENCES COM Call 1,800 -76.00 24 -77.78 n/a n/a n/a
2017-08-11 2017-06-30 13F COHERUS BIOSCIENCES COM Call 7,500 50.00 108 1.89 n/a n/a n/a
2017-05-12 2017-03-31 13F COHERUS BIOSCIENCES COM Call 5,000 106 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-02-12 2018-12-31 13F COHERUS BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F COHERUS BIOSCIENCES COM Put 500 -50.00 8 -42.86 n/a n/a n/a
2018-08-10 2018-06-30 13F COHERUS BIOSCIENCES COM Put 1,000 -23.08 14 0.00 n/a n/a n/a
2018-05-11 2018-03-31 13F COHERUS BIOSCIENCES COM Put 1,300 -45.83 14 -33.33 n/a n/a n/a
2018-02-12 2017-12-31 13F COHERUS BIOSCIENCES COM Put 2,400 9.09 21 -27.59 n/a n/a n/a
2017-11-13 2017-09-30 13F COHERUS BIOSCIENCES COM Put 2,200 -56.86 29 -60.27 n/a n/a n/a
2017-08-11 2017-06-30 13F COHERUS BIOSCIENCES COM Put 5,100 466.67 73 284.21 n/a n/a n/a
2017-05-12 2017-03-31 13F COHERUS BIOSCIENCES COM Put 900 50.00 19 11.76 n/a n/a n/a
2017-02-10 2016-12-31 13F COHERUS BIOSCIENCES COM Put 600 17 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.